𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia

✍ Scribed by Piccaluga, P P; Martinelli, G; Malagola, M; Rondoni, M; Bonifazi, F; Bandini, G; Visani, G; Baccarani, M

Book ID
110056101
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
50 KB
Volume
19
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The therapy of relapsed acute leukaemia
The therapy of relapsed acute leukaemia in adults
✍ Mark R Litzow πŸ“‚ Article πŸ“… 2004 πŸ› Elsevier Science 🌐 English βš– 438 KB

Although the cure of acute leukaemia has improved significantly, many patients will still relapse and die. The unraveling of the molecular pathogenesis of acute leukaemia has lead to the identification of new prognostic factors and improved the detection of minimal residual disease. The treatment of

Clofarabine and high-dose cytosine arabi
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
✍ Eric Tse; Anskar Y. H. Leung; Joycelyn Sim; Harold K. K. Lee; Herman S. Y. Liu; πŸ“‚ Article πŸ“… 2011 πŸ› Springer 🌐 English βš– 98 KB

Clofarabine (40Β mg/m^2^/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2Β g/m^2^/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (__N__ = 4) and relapsed (__N__ = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myel